Trial intelligence / Profile preview

UCON trial: Ulipristal acetate vs levonorgestrel IUS for heavy menstrual bleeding

2014-003408-65Phase 3Unknown

Sponsor
University of Edinburgh
Start
Dec 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of ulipristal in hypermenorrhea and Fibromyoma (LM) (2 arms), sponsored by University of Edinburgh. Primary endpoint: Menorrhagia Multi-Attribute Scale at 12 months. Status: unknown.

02

Drugs

ulipristal
03

Conditions

hypermenorrheaFibromyoma (LM)

Beyond the preview

Go deeper on 2014-003408-65.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003408-65.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call